Streamlined workflow solutions for cell and gene therapy analytics
Sponsor
Throughout preclinical development and cell and gene therapy commercialization, analytical assays are essential to produce safe and potent drug products. Despite their importance, conventional analytical assays often consist of complex manual handling steps. Therefore, it can be unclear whether variations measured come from the drug product or if they have been unwittingly introduced by the operator or technology used.
Miltenyi Biotec has compiled a complete workflow solution for precise, easy-to-handle and fast cell and gene therapy analytical assays to overcome these challenges in early discovery, cell therapy quality control during manufacturing, and patient monitoring research. Join this webinar to discover how standardization and automation enable a smooth transition from early discovery to clinical readiness!
- Facilitate target discovery through imaging platform selection
- Minimize non-specific background signal from antibodies and CAR detection reagents
- Accelerate your workflow and increase reproducibility using dry antibody cocktails
Analyze multiple cytokines in parallel using multiplex cytokine assays
Enable fully automated data acquisition and analysis on MACSQuant flow cytometers
SPEAKERS
You might also like
Same-section spatial multiomics: a platform for detailed analysis of the solid tumor TME
Pure and simple: understanding LNP analytics for better mRNA-based drugs
Empowering patient care: in-process and quality control solutions for cellular therapies
T cells from beginning to end: optimizing leukopak and drug product cryopreservation
